TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Four more vaccines in pipeline

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, April 12

Advertisement

As the government moved to ease vaccine supplies, Biotechnology Secretary Renu Swarup today said four more vaccines were in advanced stages of development in India.

Advertisement

“The DNA vaccine candidate by Zydus Cadila is currently in Phase III clinical trial stage. The protein subunit vaccine developed by Biological E has completed Phase II clinical trials.

Shot in the arm

  • Zydus Cadila’s DNA vaccine in Phase III trials
  • Biological E’s protein subunit vaccine through Phase II trials
  • Gennova’s RNA vaccine candidate in Phase I trials
  • Bharat Biotech’s intranasal vaccine in Phase I trials

The messenger RNA vaccine candidate by Gennova and the replication deficient adenoviral intranasal vaccine by Bharat Biotech are currently in Phase I clinical trial stage of development,” Swarup told The Tribune today. On Sputnik V, the non-replicating viral vector vaccine developed by Gamaleya Institute of Russia, Swarup said Dr Reddy’s had concluded large late-stage clinical trials on it in India and the data was shared with the regulator as per requirements. — TNS

Advertisement

Advertisement
Show comments
Advertisement